Aptsiauri N - Search Results

1

Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis.

Mullins RF, Aptsiauri N, Hageman GS. Mullins RF, et al. Among authors: aptsiauri n. Eye (Lond). 2001 Jun;15(Pt 3):390-5. doi: 10.1038/eye.2001.142. Eye (Lond). 2001. PMID: 11450763

2

Probable autoimmune retinopathy in a patient with multiple sclerosis.

Forooghian F, Kertes PJ, Aptsiauri N. Forooghian F, et al. Among authors: aptsiauri n. Can J Ophthalmol. 2003 Dec;38(7):593-7. doi: 10.1016/s0008-4182(03)80114-x. Can J Ophthalmol. 2003. PMID: 14740802 No abstract available.

3

The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes.

Aptsiauri N, Garrido F. Aptsiauri N, et al. Clin Cancer Res. 2022 Dec 1;28(23):5021-5029. doi: 10.1158/1078-0432.CCR-21-3501. Clin Cancer Res. 2022. PMID: 35861868 Review.

4

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.

Navarro-Ocón A, Blaya-Cánovas JL, López-Tejada A, Blancas I, Sánchez-Martín RM, Garrido MJ, Griñán-Lisón C, Calahorra J, Cara FE, Ruiz-Cabello F, Marchal JA, Aptsiauri N, Granados-Principal S. Navarro-Ocón A, et al. Among authors: aptsiauri n. Pharmaceutics. 2022 Feb 25;14(3):505. doi: 10.3390/pharmaceutics14030505. Pharmaceutics. 2022. PMID: 35335881 Free PMC article. Review.

5

Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer.

Garrido MA, Perea F, Vilchez JR, Rodríguez T, Anderson P, Garrido F, Ruiz-Cabello F, Aptsiauri N. Garrido MA, et al. Among authors: aptsiauri n. Cancers (Basel). 2021 Oct 9;13(20):5046. doi: 10.3390/cancers13205046. Cancers (Basel). 2021. PMID: 34680201 Free PMC article.

6

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.

Gil-Julio H, Perea F, Rodriguez-Nicolas A, Cozar JM, González-Ramirez AR, Concha A, Garrido F, Aptsiauri N, Ruiz-Cabello F. Gil-Julio H, et al. Among authors: aptsiauri n. Int J Mol Sci. 2021 Jul 6;22(14):7248. doi: 10.3390/ijms22147248. Int J Mol Sci. 2021. PMID: 34298868 Free PMC article.

7

HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Anderson P, Aptsiauri N, Ruiz-Cabello F, Garrido F. Anderson P, et al. Among authors: aptsiauri n. Cell Mol Immunol. 2021 Mar;18(3):556-565. doi: 10.1038/s41423-021-00634-7. Epub 2021 Jan 20. Cell Mol Immunol. 2021. PMID: 33473191 Free PMC article. Review.

8

Cancer immune escape: MHC expression in primary tumours versus metastases.

Garrido F, Aptsiauri N. Garrido F, et al. Among authors: aptsiauri n. Immunology. 2019 Dec;158(4):255-266. doi: 10.1111/imm.13114. Epub 2019 Oct 1. Immunology. 2019. PMID: 31509607 Free PMC article. Review.

9

A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.

Flores-Martín JF, Perea F, Exposito-Ruiz M, Carretero FJ, Rodriguez T, Villamediana M, Ruiz-Cabello F, Garrido F, Cózar-Olmo JM, Aptsiauri N. Flores-Martín JF, et al. Among authors: aptsiauri n. Ann Surg Oncol. 2019 Aug;26(8):2631-2639. doi: 10.1245/s10434-019-07371-2. Epub 2019 Apr 22. Ann Surg Oncol. 2019. PMID: 31011905

10

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Garrido MA, Rodriguez T, Zinchenko S, Maleno I, Ruiz-Cabello F, Concha Á, Olea N, Garrido F, Aptsiauri N. Garrido MA, et al. Among authors: aptsiauri n. Immunogenetics. 2018 Nov;70(10):647-659. doi: 10.1007/s00251-018-1074-2. Epub 2018 Aug 25. Immunogenetics. 2018. PMID: 30145665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page